期刊文献+

新疆维、汉族青春期多囊卵巢综合征特点及治疗探讨 被引量:3

Approach the characteristics and treatments of the puberty polycystic ovary syndrome of the Uygurs and Hans in Xinjiang.
下载PDF
导出
摘要 目的:研究新疆维、汉族青春期多囊卵巢综合征(PCOS)的临床特点及复方醋酸环丙孕酮治疗的临床疗效和安全性。方法:调查新疆94例(维族39例,汉族55例)青春期PCOS患者的临床特征并随访观察复方醋酸环丙孕酮治疗6个周期前后的临床特征、血清性激素水平、卵巢超声相的变化以及副反应。结果:(1)临床特征:青春期PCOS患者的初潮年龄与正常女性相同。主要症状为闭经、月经稀发及月经不规律等月经异常。维族患者出现闭经者较汉族多(P<0.05);体检发现多毛,维族患者体毛普遍较汉族多(P<0.05),维族LH/FSH>2者较汉族多;痤疮则表现为汉族多于维族(P<0.05)。月经周期维族较汉族长(P<0.05);(2)治疗后,61例PCOS患者恢复自然月经。多毛和痤疮评分明显下降(P<0.05)。血清各性激素水平,如雌二醇(E2)、黄体生成素(LH)、促卵泡素(FSH)、LH/FSH、睾酮(T)、硫酸脱氢表雄酮(DHEAS)、游离睾酮指数(FAI)均下降,差异有统计学意义(P<0.05),性激素结合球蛋白(SHBG)增加(P<0.05)。双侧卵巢体积及双侧卵泡数量减少(P<0.05)。副反应轻微。复方醋酸环丙孕酮对维、汉族青春期PCOS患者治疗效果无统计学差异。结论:新疆维、汉族青春期PCOS患者的临床表现有一定差异。复方醋酸环丙孕酮可改善青春期多囊卵巢综合征患者的高雄激素症状及内分泌状况,对恢复排卵有一定的疗效。 Objective:To investigate the clinical features of the puberty polycystic ovary syndrome(PCOS) between the Uygurs and Hans in Xinjiang,and study the efficacy and safety of compound cyproterone acetate in the treatment of the puberty PCOS. Methods: Ninty-four patients ( including the Uygurs 39 patients and Hans 55 patients) of puberty PCOS were examed and received compound cyproterone acetate for 6 cycles. Serum sex hormone, pelvic uhrasonog- raphy,the clinical features were evaluated before and after 6 cycles treatment. Results: ( 1 ) Compared with the normal women, there was no different in the menarche in the puberty PCOS patients, but the major criteria was different. Body-hair in the Uygurs was much more than that of Hans and acne was less than that of Hans. Menstrual cycle was longer than that of Hans. (2) Sixty one patients had regular menstruation during compound cyproterone acetate therapy. Hirsute and acne score decreased significantly ( P 〈 0. 05 ). Serum estradiol ( E2 ), luteinizing hormone ( LH ), follicle stimulating hormone ( FSH ), LH/FSH, testosterone ( T), dehydroepiandrosterone (Ds) and free androgen index ( FAI ) decreased significantly ( P 〈 0. 05 ), while sex hor-mone binding globin(SHBG) increased significantly( P 〈 0.05 ). Bilateral ovarian volumes as well as follicle numbers decreased significantly (P 〈 0.05 ). Serum high density lipoprotein (HDL) increased significantly ( P 〈 0.05 ), while serum total cholesterol ( TC ) decreased significantly(P 〈 0.05). Conclusion: There are some differences in clinical features between the Uygurs and Hans in the puberty PCOS patients. Compound cyproterone acetate has antiandrogenic effects on adolescent PCOS patients and improve their edocrine and of ovulation. It is effective in treatment of adolescent girls with PCOS.
作者 林琳 丁岩
出处 《现代妇产科进展》 CSCD 北大核心 2008年第4期281-285,共5页 Progress in Obstetrics and Gynecology
关键词 青春期 多囊卵巢综合征 乙酸环丙孕酮 雄激素增多症 内分泌腺 Puberty Polycystic ovary syndrome Cyproterone acetate Hyperandrogenism Endocrine glands
  • 相关文献

参考文献12

  • 1Carmina E. Diagnosis of polycystic ovary syndrome:from NIH criteria to ESHRE-ASRM guidelines [ J ]. Minerva Gineco1,2004,56 : 1-6
  • 2Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women[J]. J Clin Endocrinol Metab,1961,21: 1440-1447
  • 3Armstrong VL, Wiggam MI, Ennis CN, et al. Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate [ J ]. QJM, 2001,94:31-37
  • 4Aydinlik S, Kaufmann J, Lachnit-Fixson U, et al. Long- term therapy of signs of androgenization with a low-doses antiandrogen-estrogen combination [ J ]. Clin Trials J, 1990,27:392-402
  • 5卢春华,王蔼明,李美芝,乔杰,张富青.青春期和成年多囊卵巢综合征的比较[J].北京医科大学学报,1998,30(5):454-456. 被引量:19
  • 6姜艳华,陈咏健,李美芝.青春期不同月经方式的多囊卵巢综合征120例育龄期内分泌状态的研究[J].中国实用妇科与产科杂志,2002,18(7):406-408. 被引量:11
  • 7Homburg R, Lambalk CB. Polycystic ovary syndrome in adolescence : a therapeutic conundrum [ J ]. Hum Reprod, 2004,19 : 1039-1042
  • 8Rosenfield RL. Ovarian and adrenal function in polycystic ovary syndrome [ J ]. Endocrinol Metab Clin North Am, 1999,28 : 265-293
  • 9Jakimiuk A J, Weitsman SR, Navab A, et al. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed inthecal and granulosa cells from polycystic ovaries[ J ]. J Clin Endocrinol Metab,2001,86: 1318-1323
  • 10Ajossa S, Guerriero S, Paohti AM, et al. The treatment of polycystic ovary syndrome [ J ]. Minerva Ginecol, 2004, 56 : 15-26

二级参考文献3

共引文献73

同被引文献13

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部